semaglutide oral fda approval Approves High-Dose 25mg Novo Nordisk wins EU approval

Do not chug it, as large volumes of fluid consumed quickly can trigger nausea, especially on GLP-1 medications

Promotes weight loss Semaglutide may contribute to weight management when combined with a healthy diet and exercise by reducing appetite and increasing feelings of fullness

A 2025 study found a modest increase in osteoporosis risk among GLP-1 users, roughly a one-third increase in relative terms

This milestone reinforces the companys commitment to expanding access to advanced therapies for chronic metabolic diseases, including type 2 diabetes

Over time, this cycle can cause chronically high insulin and blood sugar levels, leading to weight gain, fatigue, and eventually type 2 diabetes if left untreated

Both medications reduce alcohol tolerance, and the transition period when drug levels are unpredictable makes alcohol sensitivity even less predictable